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To identify choliinergically mediated components in the optic nerve response (ONR) we studied 
effects of cholinergic agonists and antagonists in the arterially perfused cat eye. Acetyleholine, 
carbachol, scopolamine, quinuclidinylbenzilate and mecamylamine were applied intra-arterially in 
micromolar concentrations. Recordings of rod-and cone-driven ERG accompanied those of the 
ONR and revealed: (i) cholinergic agonists enhanced the b-wave, particularly under photopic 
conditions, whereas scopolamine decreased the b-wave. Mecamylamine induced biphasic effects 
(decrease followed by increase) in the amplitudes of the rod-and cone-driven b-waves. The effects 
on the cone-driven ERG were more marked than those on the rod-driven ERG. (ii) The ON- 
component of the ONR was increased, then decreased by aeetylcholine. The cholinergic antagonists 
exerted complex changes in the ONR-ON component depending on dosage and adaptation. 
Scopolamine increased, then decreased the rod-driven ON-component, but mainly increased the 
cone-driven ON-component. Mecamylamine tended to increase the cone-driven, but to decrease the 
rod-driven ON-component of the ONR. (iii) The configuration of the rod- as well as for the cone- 
driven ONR, in particular the early plateau and OFF-components, were consistently and reversibly 
changed by cholinergic agonists, as well as by both muscarinic and nicotinic antagonists. Agonists 
decreased, and antagonists increased the amplitude of the plateau-component. We conclude that 
the ERG b-wave was enhanced by acetylcholine, but decreased by cholinergic antagonists. 
Cholinergic agonists and antagonists affect the same specific components of the ONR in a dose- 
related and rewersible fashion, indicating a major contribution of cholinergic mechanisms to 
information processing in the cat retina. 
Optic nerve response ERG Cones Rods Cat retina Acetylcholine 
Muscarinic Nicotinic 
Cholinergic antagonists 
INTRODUCTION 
Cholinergic neurons haw~ been identified in a variety of 
mammalian retinae (Puro, 1985), such as rabbit (Mas- 
land, 1980; Tauchi & Masland, 1984), cat (Pourcho & 
Osman, 1986; Pourcho & Osman, 1987; Schmidt, 
Humphrey & W/issle, 1987), rat (Eckenstein, Schwab 
& Thoenen, 1981) and human (Hutchins & Hollyfield, 
1987). Both nicotinic and muscarinic receptors have been 
shown (Pourcho & Osman, 1987; Zarbin, Wamsley, 
Palacios & Kumar, 1986). The consistent morphological 
features uggest a significant physiological role of the 
*The data have, in part, been presented at ARVO, May 1994 and at the 
annual meeting of the German Ophthalmological Society, Septem- 
ber 1994. 
tTo whom correspondence should be addressed: Neurophysiology 
Laboratory, Department of Ophthalmology, University Hospital, 
8091-Z~irich, Switzerland [Fax 41 1 255 4438]. 
cholinergic systems in mammalian retina. However, 
electrophysiological studies on the function of acetylcho- 
line (ACh) and effects of cholinergic and anticholinergic 
drugs in the retina revealed partly controversial results: 
several authors reported ACh mediated inhibitory effects 
on ON-centre ganglion cells and excitatory effects on 
OFF-centre ganglion cells (Straschill, 1967; Straschill & 
Perwein, 1973), while others reported that ACh pre- 
dominantly increases the light-evoked activity of Y cells 
(with a periphery effect), but not of X cells (Ikeda & 
Sheardown, 1982). Strong cholinergic input was shown 
in ON and ON/OFF directional sensitive ganglion cells 
that costratify with cholinergic amacrine cells in the 
rabbit (Masland & Ames, 1976; Famiglietti, 1983). In 
addition, a spontaneous, light-independent release of 
ACh was suggested (Ariel & Daw, 1982a; Masland, 
1982), and ACh was found to regulate the level of 
ganglion cell maintained activity in the rabbit retina 
(Ariel & Daw, 1982a; Ariel & Daw, 1982b). Schmidt et 
al. (1987) observed that ACh increased the light-induced 
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FIGURE 1, Effects of cholinergic agents on the rod-driven b-wave: the time-course ofchanges in normalized amplitudes of the rod-driven b-wave 
is plotted in response to ACh (A), to scopolamine 03) and to mecamylamine (C). The changes are plotted as a percentage of the control values 
(100%). ERGs were evoked every 60 sec by 400 msec flashes using a long wavelength band filter matched to a corresponding short wavelength 
band filter, attenuated by 3-4 log units with neutral density filters for selective rod stimulation. The beginning of the changes in response to 
cholinergic agents was set at 0 rain, and the duration of injection was adjusted to the time to reach a steady state in this and subsequent figures. 
ACh (A) (18--1600/zM) was injected for 10-35 vain and induced, although with some variability, an increase in b-wave up to 200%. ERG traces, 
control and 400/aM ACh, cal. 100/aV. Scopolamine (B) (210-1000/aM) was injected for 17 mill. Concentrations in the range of 500-1000/aM 
usually induced a decrease in b-wave by 20-40%. Mecamylamine (C) (120-1000/aM) was injected for 10-17 rain. The b-wave was clearly 
decreased up to 40% by concentrations above 120 #M. 
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and spontaneous activity of all ON-and OFF-, X- and Y- 
cells. 
The primary goal of the present study was to detect an 
expression of cholinergic activity and to assess qualita- 
tively its relative functional weight in the light-evoked 
compound action potential of the optic nerve [optic nerve 
response (ONR)]. In parallel, effects of cholinergic 
agonists and antagonists on the b-wave of the ERG were 
recorded. We used the isolated arterially perfused cat eye 
preparation to study effects of cholinergic agents on 
retinal function. This in vitro preparation comprised the 
following advantages: (i) the chemical input to the 
perfused eye can be controlled; (ii) systemic variables 
and extraocular metaboli,;m are excluded; (iii) ERG and 
ONR can be recorded simultaneously to ascribe ffects to 
the outer or inner retinal !layers, respectively; (iv) effects 
of chemical agents on the retina can be assessed in the 
presence of intact retinal pigment epithelium and retinal 
vascular system (Niemeyer, 1981). It will become 
evident hat cholinergic agonists and antagonists mod- 
ulate the light-evoked electrical field responses, provid- 
ing further physiologiical evidence of powerful 
contribution of cholinergic mechanisms in retinal signal 
processing. 
METHODS 
The experiments were ,carded out on 13 cats (16 eyes) 
and in accordance with the ARVO resolution on the use 
of animals in research and with the regulations of the 
cantonal veterinary authority of Ziirich. The details on 
the method (anaesthesia, pplication of drugs to the 
perfused cat eye and :signal recordings) have been 
published previously (Niemeyer, 1981; Niemeyer, 
1992; Uji & Niemeyer, 1989). 
Anaesthesia 
After premedication with atropine sulphate (0.02- 
0.04 mg/kg body wt s.c.) and ketamine hydrochloride 
(Ketalar, 10-20mg/kg body wt, i.m.) the cats were 
intubated, paralysed by gallamine triethiodide (Flaxedil, 
5-10mg/kg body wt, i.v.) and anaesthetized with 
pentobarbital hydrochloride (Nembutal, Abbott Lab., 
North Chicago, IL., 9-16 mg/kg body wt, i.v.). Muscle 
relaxation and deep anaesthesia were maintained by 
continuous pump driven i.v. application of gallamine 
triethiodide and pentobarbital hydrochloride, respec- 
tively (Hirsch-Hoffmann & Niemeyer, 1994). Prior to 
surgical procedures, fentanyl (0.05 mg i.v., Janssen, Baar, 
Switzerland) was applied to ensure complete analgesia. 
The electrocardiogram, oxygen saturation and expiratory 
CO2 were monitored continuously (Pulsoxi satlite plus 
and a Normocap CO2 monitor, Datex instruments Corp., 
Helsinki, Finland). For artificial respiration with room 
air, enriched with oxygen to 30%, we used a respiration 
pump (model 66 IA, Halrvard Apparatus, South Natick, 
Mass.). Oxygen saturation >94% and tidal expiration of 
4% CO2 was maintained throughout the anaesthesia. 
Body temperature (38-39°C) was regulated by a heating 
pad and monitored by a rectal probe. Sodium chloride 
infusion (0.9%, 10 ml/kg/hr) and occasionally Macrodex 
70 (6%) were used to maintain fluid and electrolyte 
balance. Prior to enucleation of the first eye, we injected 
heparin for anticoagulation (Liquemin, 1000U/ml/kg, 
Roche, Basel, Switzerland), and immediately after 
enucleation a corresponding amount of protamine 
hydrochloride i.v. (1000 U/ml/kg, Protamin 1000, Roche, 
Basel, Switzerland). 
Surgery and perfusion 
After atropine- and phenylephrine-induced mydriasis 
the eye was enucleated in deep anaesthesia. Following 
cannulation of the ophthalmociliary artery, the eye was 
perfused with oxygenated (pO2 400-450 mm Hg) tissue 
culture medium TC 199, modified with Earle's salts and 
L-glutamine, 200 mM (Bio Concept, Allschwil, Switzer- 
land), amikacin-sulphate (63.9/~M; Amikin, Bristol- 
Myers Squibb AG, Baar, Switzerland) and newborn calf 
serum (30%). The perfusate was buffered with HEPES 
(15 mmol/1) and NaHCO3 (26 mmol/l). The pH of the 
filtered (Millipore, 0.22/~m pore size) perfusate was 
adjusted to 7.4 and the temperature was maintained at 
37°C. Oxygenation of the perfusate was done by 
bubbling with 95% 02 and 5% CO2 for 25 min at a rate 
of 150 ml/min. 
Stimulation and electrical recording 
The d.c. ERG was recorded with an intravitreal salt 
bridge electrode and a similar reference electrode on the 
scleral surface at the posterior pole of the eye. The 
monophasic negative compound action potential of the 
optic nerve, the light-evoked ONR, reflecting the 
summed activity of ganglion cells conducted by the 
axons, was recorded with Ag-AgCI electrodes: the 
position of the reference lectrode was on the surface 
of the optic nerve, while the active (suction) electrode 
was placed on the proximal cut end of the optic nerve. 
The light source for the stimuli was a 150 W xenon arc 
lamp providing a maximum of l l.541ogquanta 
[scot. 507 nm] deg -2 sec -1. The stimuli were applied 
with a modified fundus camera in Maxwellian view 
(Gouras & Hoff, 1970). Attenuation of the light flashes 
was performed with neutral density filters and mono- 
chromatic filters to achieve rod matched conditions in full 
dark adaptation. The duration of the stimulus was 
400 msec with an interval of 60 sec. For the stimulation 
of the cone system, an adapting beam (white background; 
2 1 8.6 log quanta [scot. 507 nm] deg- sec- attenuated by 
2.0-3.0 log units) was switched on to suppress the rod 
contribution, and white flashes were attenuated by 1.0- 
2.0 ND to elicit cone-driven responses. At the beginning 
of the electrophysiological recordings, immediately after 
the onset of perfusion, 20 msec standard red light pulses 
(delivered at 30 see intervals) were used to monitor the 
increase in sensitivity during dark adaptation for at least 
60 min. The perfusion rate was adjusted (1-2.5 ml/min) 
until the b-wave reached an amplitude of 700-800/~V. 
The d.c. recordings of the ERG and standing potential 
were amplified (PARC 113, EG and G, Munich, 
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FIGURE 2. Effects of cholinergic agents on the cone-driven b-wave. The time-course of changes in normalized amplitudes of 
the cone-driven b-wave is plotted in response to ACh (A), to scopolamine (B) and to mecamylamine (C). The changes are 
plotted as a percentage of control values (100%). ERGs were evoked every 60 sec by 400 msec flashes of white light, attenuated 
by 1-2 log units with neutral density filters. A rod suppressing white background was switched on. ACh (18--1600/tM) was 
injected for 10-25 min and induced an increase in the b-wave up to 400%. ERG traces, control and 800/tM ACh, cal. 100/tV. 
Scopolamine (200-1000 #M) was injected for 10-30 min and induced a decrease in the b-wave by 20-80%. Mecamylamine 
(200--1000/tM) was injected for 10-15 min. The b-wave clearly decreased by up to 100% and increased by up to 350%. 
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Germany) and fed to a digital oscilloscope (Gould digital 
storage oscilloscope 4050, Cleveland, OH, U.S.A.) and to 
an FM magnetic tape recorder. On another channel the 
ERG was filtered (low cut-off range 0.03-1 Hz; high cut- 
off range 40-300 Hz; Kiohn-Hite filter 3750, Tectron 
AG, Bubikon, Switzerland), recorded on an oscilloscope 
and an FM magnetic tape. The ONR was filtered to a low 
cut-off and a high cut-off usually ranging from 0.02 to 
100 Hz. The ERG and ONR were also written on a four- 
channel chart recorder (Gould RS 3400, Cleveland, OH, 
U.S.A.) using the analogue outputs of the digital 
oscilloscope. The data were in part recorded and analysed 
by Labview for Windows (National Instruments, En- 
netbaden, Switzerland), programmed by A. Kaelin-Lang 
(Kaelin-Lang & Niemeyer, 1995). The flow rate of 
perfusion was continuou,dy recorded via a drop-interval 
meter with an analogue voltage output. Constant 
hydrostatic pressure drave the perfusion system, and 
changes in flow rate rettected potential pharmacologi- 
cally induced changes in total resistance of the vascular 
system of the choroidal, ciliary and retinal circulation. 
At the beginning of each pharmacological trial 
(referred to as series)control signals were recorded 
before the drugs were injected intra-arterially (10-50 min 
duration) into the perfusate by pump driven syringes 
(Perfusor Secura B. Braun, Bender and Hobein, Ziirich, 
Switzerland; Harvard Apparatus 22, Harvard Apparatus, 
South Natick, MA, U.S.A.). After having reached a 
steady state of the effects, application of the drug was 
stopped, and wash-out was allowed usually for 30- 
50 min. 
Since some dead space within the perfusion system 
resulted in a delay betwe,en the beginning of an injection 
and first effects (on standing potential, flow rate or signal 
size) we chose to desigvLate "zero time" in all illustra- 
tions as the last point in lime before the onset of the first 
effect. This should improve clarity and the possibility to 
compare effects. Howeuer, exact times after start of 
injections are listed in Table 1. Series with marked 
changes in flow were listed in the table, and marked 
separately in the illustrations that show maximal effects 
vs concentration f the cholinergic agents. 
Agents 
Several drugs were chosen to study cholinergic effects 
on the flow rate of the perfusate, the b-wave of the ERG 
and the ONR: as cholinergic agonists, ACh (acetylcho- 
line chloride) and carbachol (carbamylcholine chloride) 
were applied in concentrations of 18-1600/aM (14 series, 
5 eyes) and 20-80/aM (nine series, 4 eyes), respectively 
(Sigma, St Louis, MO, LI.S.A.). 
As cholinergic antagonists, quinuclidinylbenzilate 
(QNB) (gift from Dr H. Bittiger, Research and Develop- 
ment Department of the Pharma Division, Ciba Geigy, 
Basel, Switzerland) and scopolamine (scopolaminhydro- 
bromide, Sigma, St Louis, MO, U.S.A.) were applied in 
concentrations of 55-1613/aM (three series, 3 eyes) and 
200-1000/aM (10 series, 3 eyes) respectively. The 
nicotinic antagonist m,ecamylamine (mecamylamine- 
HC1, provided by Merck, Sharp and Dohme Research 
Laboratory, Rahway, NJ, U.S.A.) was applied in 
concentrations of 120-1000/aM (12 series, 5 eyes). 
QNB and carbachol were used mainly in preliminary 
studies and their effects are not included in detail in this 
report. 
RESULTS 
Effects of ACh on the b-wave 
As shown in Fig. I(A), ACh enhanced the rod-driven 
b-wave. During the intra-arterial injection ACh (18- 
1600/aM) induced a clear, although variable increase in 
the b-wave amplitude. The increase ranged from + 7% to 
+ 111% and was seen in six out of eight series. Figure 
3(A) shows the maximal changes in b-wave amplitudes in
relation to the concentration of ACh. A maximum 
increase in rod-driven b-wave was observed at lower 
concentrations (18-150/aM). Two series (100 and 
200/aM) revealed a decrease in the b-wave by -14% 
and -20%, but in both cases the recovery was not 
complete. A clear dose dependency of the effects on the 
rod-driven b-wave was not seen. In contrast, ACh 
consistently induced an increase in the cone-driven b- 
wave in a dose-dependent manner as shown in Figs 2(A) 
and 3(A). Maximal concentrations of ACh (1600 #M) 
caused the highest increase of the b-wave amplitude 
(+ 314%), while lower concentrations (18/aM) increased 
the b-wave by 37%. Thus ACh induced a larger increase 
in the cone-mediated than in the rod-mediated b-wave 
amplitude. 
Effects of muscarinic and nicotinic antagonists on the 
b-wave 
The decreasing action of the muscarinic antagonist 
scopolamine on the rod-driven b-wave is illustrated in 
Fig. I(B): 210 #M had only weak effects ( -  5%), while 
higher concentrations caused a decrease in b-wave in a 
range of - 22% (500 pM) to - 39% (1000 #M). The 
maximal effects of scopolamine on b-wave revealed an 
indication of dose relation except for 200/aM (rod- 
driven) vs 230/aM [cone-driven; Fig. 3(B)]. Incremental 
steps of 200 and 400/aM scopolamine induced an 
increase in rod-driven b-wave amplitude by 39% and 
65%, respectively. However, this increase in b-wave was 
not reproducible in further experiments. 
The nicotinic antagonist mecamylamine, in contrast, 
had biphasic effects on the rod-driven b-wave during the 
injection inducing a decrease in amplitude of the rod- 
driven b-wave ( -  10% to - 65%), frequently followed 
by a rapid increase (Fig. 1). The increase was most 
obvious with concentrations of 500/aM mecamylamine 
(+ 30%), and the threshold ose was around 120/aM. 
Three series of mecamylamine (one eye) revealed a 
maximal decrease between 40% and 60%. However, an 
accompanying decrease inthe flow rate by about 22-30% 
may be responsible in these particular series, since 
reduction in flow rate of perfusion decreases the 
amplitudes of light-evoked signals. 
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Depressant effects of scopolamine on the b-wave 
amplitude were observed under both rod- and cone- 
stimulus conditions, and were more pronounced in the 
latter (Fig. 3). 
Depressant effects of mecamylamine on the cone- 
driven b-wave were observed in the range of 22-100%. A 
maximal depressant effect on the cone-driven b-wave 
was induced at concentrations of 200 and 500 #M. The 
decrease in b-wave amplLitude was followed by a rapid 
increase of 28-340% at concentrations of 500, 944 and 
1000/zM (n=3; Fig. 2). Interaction with the flow 
decreasing effects of mecamylamine is considered in 
interpreting this complex response pattern. 
Effects of ACh on the ONR 
Original traces and amplitude over time plots, reflect- 
ing changes in ONR amplitude to illustrate the effects of 
cholinergic agents are shown in Figs 4-7. The controls in 
Fig. 4 represent typical ONRs: during the onset of a 
400msec light stimulus the initial ON-component 
appears, followed by a plateau, representing mainly tonic 
ganglion cell activity. 'Ihe OFF-component, following 
the termination of the stimulus, showed more variability 
than the ON-component and the plateau, due to expected 
complex interaction of the many types of ganglion cell 
firing patterns (Niemeyer, 1989). 
The effects of cholinergic agonists on the rod-matched 
ONR are shown in representative examples in Fig. 4(A). 
At the beginning of the injection, the ON-component 
often increased temporarily (5-10%; Figs 5 and 7) before 
exhibiting a long lasting, marked ecrease in amplitude. 
Configurational examination revealed that ACh induced 
a more pronounced decrease in the OFF-component (50- 
95%) than in the ON-component (8-40%). However, the 
OFF-component was not always distinct and measurable 
at the low stimulus intensity used here. The effects of 
ACh also comprised a decrease in the initial plateau 
phase (Fig. 8). Preliminary studies with carbachol 
revealed a more pronounced depression of the plateau, 
while the OFF-component showed a smaller decrease 
than seen with ACE l_~wer concentrations of carbachol 
increased the ON-component [Fig. 4(A)]. As shown in 
Fig. 5, we recorded a small transient increase (5-10%) in 
the ON-component in four rod-driven series, as well as in 
two cone-driven series (Fig. 6) followed by a long lasting 
decrease (Table 1). 
This effect of ACh, representing a decrease in the rod- 
driven ON-component, was observed in each series 
(n = 8). The changes in the ONR ON-component are 
summarized in Fig. 7. The maximal ACh-induced 
decrease was observed at low concentrations ( -  40%), 
while higher concentrations had less depressant effects. 
The effects of ACh on the cone-driven ONR are 
represented in original traces in Fig. 4(B). ACh induced 
changes similar to those seen under rod stimulus 
conditions. Figure 7 includes the effects of ACh on the 
ON-component ofthe cone-driven ONR, with a maximal 
decrease of -5% to -17% (n = 6). As shown in Fig. 6, 
an initial increase of + 2% to + 8% was observed in two 
out of six series. 
In summary, the effects of intra-arterially applied ACh 
revealed characteristic time-courses. The effects ap- 
peared first as an enhancement of the b-wave while the 
ONR ON- and OFF-components decreased. Recovery 
was seen first in the b-wave. The ONR ON-component 
usually recovered within 60 min of the beginning of ACh 
injection. The OFF-components were decreased more 
than the ON-components. The b-wave increased more 
under cone than under rod stimuli, while the ONR 
decreased more under od than under cone stimuli. 
Effects of muscarinic and nicotinic antagonists on the 
ONR 
Typical effects of cholinergic antagonists on the rod- 
matched ONR are shown in Fig. 4(A). This illustrates the 
late effects of scopolamine decreasing the ON-compo- 
nents, while a pronounced augmentation f the plateau 
and the OFF-components was typically found. These 
effects were also observed under administration of the 
muscarinic antagonist QNB in preliminary studies, seen 
as an early effect in Fig. 4(A). Furthermore, the ON- 
component, plateau and OFF-component were strongly 
depressed by QNB (late effect). Figure 5 depicts, in 
amplitude vs time plots, a dose-dependent, transient 
increase, and then a decrease in the ON-component 
induced by scopolamine in concentrations of 210- 
1000/zM. The decrease was observed immediately after 
stopping the injection. However, scopolamine transiently 
induced an increase in the ON-component during 
FIGURE 3. Maximal changes in normalized b-wave amplitudes in relation to the concentration f cholinergic agents. Several maxima were 
obtained from series with incremental concentrations. The solid symbols represent rod-driven responses and the open symbols cone-driven 
responses. 0% represents he control prior to the induced changes (- - -). ACh (A): a dose-rdatod response was apparent only for the cone-driven 
b-wave. It was increased further in response to ACh than the rod-driven b-wave. Scopolamine (B): a dose-dependent relation was apparent for 
both rod- and cone-driven b-wave. An increase in rod-driven b-wave in response to scopolamine (200-400 #M) was recorded in one eye, while 
the other series clearly showed a decrease in response to scopolamine. The cone-driven b-wave was more decreased than the rod-driven b-wave. 
Mecamylamin¢ (C): the b-wave was decreased under both rod and cone stimulation. A biphasic effect of mecamylamine on the b-wave was 
observed in five series (arrows): a decrease in cone-driven b-wave followed by an increase was recorded in three series. Two series (one rod- 
driven, one cone-driven) represent an increase in b-wave followed by a decrease. Effects of cholinergic agents on the cone-drivan b-wave. The 
time-course of changes in normalized amplitudes of the cone-driven b-wave was plotted in response to ACh (A), to scopolamine (B) and to 
mecamylamine (C). The changes were plotted as a percentage of control values (100%). ERGs were evoked every 60 sec by 400 msec flashes of 
white light, attenuated by 1-2 log units with neutral density filters. A rod suppressing white background was switched on. ACh (18-1600/zM) was 
injected for 10-25 rain and induced an increase in the b-wave up to 400%. Scopolamine (200-1000 #M) was injected for 10-30 min and induced a
decrease in the b-wave by 20-80%. Mecamylamine (200-1000 #M) was injected for 10-15 min. The b-wave clearly decreased by up to 100% and 
increased by up to 350%. 
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FIGURE 5. Effects of cholinergic agents on the rod-driven ONR: time-course of changes in normalized amplitudes of the ON- 
component of the rod-driven ONR in response to ACh (A), scopolamine (B) and mecamylamine (C). The changes are plotted as 
a percentage of control (100%). ACh (18-1600/aM) was injected for 10-35 min and induced a transient increase followed by a 
decrease in ON-component by 40%. Scopolamine (210-1000/aM) was injected for 17 min. 210 and 500/aM revealed an initial 
increase followed by a small decrease during injection. 1000/aM clearly induced an increase by up to 20% during injection. The 
ON-component was remarkably decreased by 70% immediately after termination of the injection. Mecamylamine (120- 
1000/aM) was injected for 10-17 min. The ON-component was changed with large variability, but configurational changes 
were more reproducible [Fig. 4(A, B)]. 
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injection by 6-20% (500 and 1000 #M). The maximal 
effects of scopolamine during injection in Fig. 7 reveal a 
threshold ose of about 200 #M, which had only weak 
effects on the ON-component (20 and 40 #M had no 
effect; not shown). 
Mecamylamine, in contrast, showed more variability 
on the rod-driven ONR in comparison to the muscarinic 
antagonist (Figs 5 and 7). 120pM mecamylamine 
revealed only a slight decrease by 10%, while concentra- 
tions of 220-1000 pM induced a decrease in the ONR 
ON-components by --40% to -52% (Fig. 7). The 
increase in the plateau was similar to that seen under 
scopolamine [Fig. 4(A) and Fig. 8]. The OFF-component 
showed much variability under mecamylamine. 
Figure 4(B) represents he effects of scopolamine and 
of QNB on the ONR in light adaptation. Both QNB and 
scopolamine had similar effects. Scopolamine (200, 230 
and 500 #M) clearly induced an increase in the ON- 
component of the cone-driven ONR by + 3% to + 24%, 
while 230 and 1000 pM decreased the ON-component by 
- 14% and by - 6%, respectively (Figs 6 and 7). 
Figure 4(B) also illustrates effects of mecamylamine 
on the cone-driven ONR: 500 and 944/~M clearly 
increased the ON-component and the plateau of the 
cone-driven ONR, in contrast to the corresponding 
changes under rod stimulus conditions. The maximal 
increase in the ON-response was about 40%, occurring 
with a delay after termination of the injection in 
concentrations of 200 and 500 #M. 1000 pM decreased 
the ON-component of the cone-driven ONR by 12% 
without recovering completely. The OFF-component, 
exhibiting more variabilky, was decreased under meca- 
mylamine. 
Cholinergic effects on the magnitude of the ONR-plateau 
Typical effects of cholinergic agents on the ONR- 
plateau are shown in Fig. 8. Cholinergic agonists [Fig. 
8(A)] decreased the plalleau. Antagonists, in contrast, 
induced a pronounced augmentation f the plateau [Fig. 
8(B)]. As shown in representative examples [Fig. 8(A)] 
ACh, applied for either 10 or 25 min, decreased the 
plateau nder both cone and rod stimuli by 55% and 30%, 
respectively. Under rod-stimulus conditions carbachol 
induced astronger decrease in the plateau than ACh, but 
under cone-stimulus conditions carbachol had weaker 
effects than ACh. The plateau decreased by 40% in 
response to incremental concentrations of carbachol. 
Cholinergic antagonists affected the plateau in an 
opposite manner. Effects of scopolamine are shown in 
representative examples in Fig. 8(B) with incremental 
steps of 20(0-400 #M. Rod-driven signals revealed an 
increase in the plateau by 110%. Mecamylamine had a 
weaker effect on the plateau, inducing an increase by 
60%. With cone stimuli both scopolamine and mecamy- 
lamine revealed similar effects, inducing an increase in 
plateau by 60%. The effects of cholinergic agents on the 
plateau of the ONR (maximal changes in %) are plotted 
against concentrations in Fig. 8(C). Agonists occasion- 
ally increased the plateau transiently prior to a more 
pronounced decrease (arrows). The antagonists, in 
contrast, increased the plateau consistently. 
Side effects of cholinergic agents on the flow rate of the 
perfusate 
Cholinergic agonists. An increase in flow rate, 
reflecting a decrease in vascular resistance of the 
perfused eye was observed in 13 out of 16 series. ACh 
increased flow rate in a range of 2-15%, while the flow 
remained unchanged in three series. 
Cholinergic antagonists. Scopolamine and mecamyl- 
amine consistently induced a decrease in the flow rate, 
corresponding to an increase in vascular esistance. In 
every case the muscarinic (scopolamine) and nicotinic 
(mecamylamine) antagonists decreased the flow rate in a 
range of 4-15%. In one preparation (three series) 
mecamylamine (220-515 pM) induced unusually large 
flow decreases of - 22% to - 30%. 
Changes in flow rate induced by the applied agents 
(Jurklies, Kaelin & Niemeyer, 1994) can per se affect he 
magnitude of the light-evoked responses in the perfused 
eye. Therefore the effects of substantial changes in flow 
rate must be considered in evaluation of electrophysio- 
logical data. Where this appeared not feasible we 
excluded the respective series from the summary graphs. 
DISCUSSION 
It was found that cholinergic agents affected ifferen- 
tially the ERG b-wave and selective components of the 
optic nerve compound action potential, ONR. These 
effects will be discussed separately. 
Cholinergic agonists and b-wave 
The ACh-induced effects on the b-wave consisted of an 
enhancement of rod- and cone-driven b-waves, which is 
in part in agreement with previous tudies in the cat in 
vivo (von Bredow, Bay & Adams, 1971) and in the 
isolated rabbit retina (Honda, 1971). These authors 
concluded that increased concentrations of ACh in retinal 
synapses are responsible for the increase in b-wave 
amplitude. It seems conceivable that enhancement of the 
b-wave amplitude xpresses feedback on bipolar cells, 
i.e. via amacrine cells (Linn & Massey, 1992; Neal & 
Cunningham, 1994). 
Any increase in amplitude of light-evoked retinal 
signals can be related to an increase in blood-or 
perfusate-flow. An increase in flow rate increases the 
oxygen supply and can enhance the b-wave in vitro 
(Niemeyer, 1973). Demant, Nagahara and Niemeyer 
(1982) reported a stability of the b-wave after changing 
mean arterial blood pressure between 55 and 225 mm Hg 
in the anaesthetized cat, but the b-wave decreased rapidly 
when the mean arterial blood pressure was lowered below 
55 mm Hg. This wide range of stability of the b-wave was 
considered to reflect an autoregulation of the blood 
supply to the retina, which keeps neural functions 
constant. According to these findings on flow effects on 
the ERG, the ACh-induced changes in the present study 
cannot be explained by the relatively small changes in 
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flow rate. Furthermore, the effects of several cholinergic 
agents affected rod-driven and cone-driven signals 
differently. If an increase in flow rate is responsible for 
the Ach-induced changes in b-wave amplitude, both the 
rod-and cone-driven b-wave would be affected equally 
by the change in flow rate. This applies as well to the 
effects on the ONR (see below). 
The effects of ACh on the cone b-wave compared to 
those on the rod b-wave suggest that ACh has stronger 
effects on the cone pathway than on the rod pathway 
within the inner nucelar ]layer. That might be related to 
the following facts: (i) cone bipolar cell connections to 
cholinergic amacrine cells (starburst or A14 amacrine 
cell) (Pourcho & Osman, 1987) were reported by 
Famiglietti (1983); (ii) the density of cholinergic 
amacrine cells is highest in the central part of the cat 
retina (Schmidt et al., 1987) corresponding to the higher 
cone density; (iii) Vivas and Drujan (1980) found that the 
ACh release in light-adapted teleost retinae was 50% 
higher than in dark-adapted retinae. 
Several authors demonstrated that cholinergic markers, 
including high affinity c]~oline uptake, choline acetyl- 
transferase, acetylcholinesterase,  well as bungarotoxin 
and muscarinic binding sites are all present in the 
proximal mammalian retina (Neal, 1983; Puro, 1985; 
Pourcho & Osman, 1987; Schmidt et al., 1987). Our 
results suggest that cholinergic mechanisms also affect 
structures that contribute to the b-wave, modulating the 
cone-driven more than the rod-driven signals. Several 
findings suggest a possib]Le cholinergic effect on the b- 
wave via Miiller cells: Hfsli, H6sli, Maelicke and 
Schr6der (1992) and H(isli, H6sli and Kaser (1993) 
detected cholinergic receptors on astrocytes, and they 
recorded electrophysiological responses mediated by 
muscarinic receptors in cultured astrocytes. Acetylcholi- 
nesterase has been located in the teleost retina (Nichols, 
Hewitt & Laties, 1972). Therefore, an effect of 
cholinergic agents on the retinal glia, the Mtiller cells, 
is conceivable via its response to changes in light-evoked 
increases in extracellular potassium concentration at the 
outer border of the inner nuclear layer. This mechanism is 
the prevailing concept for the generation of the ERG b- 
wave (Newman, 1985; Wen & Oakley, 1990). However, 
recent pharmacological separation of components pre- 
sumably contributing togeneration and termination ofthe 
b-wave indicate complex contributions from ON-and 
OFF-bipolar cells as well as from horizontal cells 
(Sieving, Murayama & Naarendorp, 1994). This aspect 
and the notion that cat S-potentials are not affected by 
cholinergic agents (Niemeyer, Albani & Schuurmans, 
1981) do not preclude the possibility of influences of 
cholinergic amacrine cells on the b-wave via feedback 
connections to rod and cone bipolar cells, that in turn 
would influence the membrane potential of Miiller cells. 
Based on this view one would expect different effects of 
cholinergic agents on the ERG compared to the ONR, as 
revealed by the present results. 
Cholinergic antagonists and b-wave 
Scopolamine and mecamylamine mainly induced a 
decrease in b-wave amplitude, a change opposite to the 
effects of ACh. These results are in part in agreement 
with a previous tudy of Niemeyer and Cervetto (1977), 
who observed a biphasic effect, a transient increase 
followed by long lasting decrease, after intra-arterial 
administration of atropine in the perfused cat eye. In 
contrast, in vivo studies of the cat (von Bredow et al., 
1971) and in vitro studies of the isolated rabbit retina 
(Nakagawa, Kurasaki, Masuda, Ukai, Kubo & Kadono, 
1988) revealed an increase in b-wave amplitude after 
administration of atropine. We observed a clear, 
scopolamine-induced increase in b-wave amplitude only 
in one preparation, and this increase was not reproducible 
in further experiments. Differences in drug application 
(yon Bredow et al., 1971) and in the experimental setup 
(Nakagawa et al., 1988) may explain this disaccord. 
While the effects of scopolamine imply a specific 
antagonistic action, changes in cone-driven b-wave 
during injection of mecamylamine donot fit completely 
in the agonist/antagonist concept. It is conceivable that 
the accompanying decerase in flow rate induced by 
mecamylamine produced the initial and probably under- 
lying decrease inb-wave, that affected to a varying extent 
the longer lasting "neural" increase in b-wave amplitude. 
The decrease in b-wave amplitude was followed by a 
marked increase under cone stimulus conditions. Non- 
specific effects in the present study may be responsible 
for these incomplete antagonistic actions of mecamyl- 
amine on the cone-driven b-wave. Nonspecific effects of 
the nicotinic antagonist dihydrobetaerythroidine were 
reported by Schmidt et al. (1987), who suggested that the 
effects may be mediated either via nonspecific binding 
sites or via binding on inhibitory interneurons. 
The different effects of scopolamine compared to those 
of mecamylamine for rod vs cone stimuli point to a 
different role of muscarinic vs nicotinic receptors: Honda 
(1971) suggested that cholinergic transmission i  the 
rabbit's retinal synapses is muscarinic rather than 
nicotinic. Our results on mecamylamine on the rod- 
driven b-wave are indicative of muscarinic as well as 
FIGURE 7. Maximal changes in normalized amplitudes of the ONR ON-components in relation to the concentration f cholinergic agents (all 
trials included). The solid symbols represent rod responses and the open symbols cone responses during infusion. A clear dose-response relation 
is not apparent for the ON-component of the rod-and cone-driven ONR in response to ACh. An initial small increase followed by a long term 
decrease in the ON-component was recorded in five out of 14 series (arrows). The maintaining effect was a decrease in ON-component of both 
rod-and cone-driven ONR. Scopolamine: a dose-response relation is apparent for the ON-component of both the rod-and cone-driven ONR. 200 
and 210 #M induced adecrease i:a the ONR, while 500 and 1000/~M mostly induced an increase in the ON-component ofboth the rod-and cone- 
driven ONR. The effects of mecamylamine were different, for the ON-component of rod vs cone-driven ONR: 500 and 944/zM induced an 
increase in cone-driven ONR, while rod-driven ONR was decreased during injection. 
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FIGURE 8. Effects of cholinergic agents on the plateau of the optic nerve responses. The time-course ofchanges in normalized 
amplitudes of the ONR plateau is shown in response to cholinergic agonists (A) and antagonists (13) in representative examples. 
The plateau was measured 200 msec after the beginning of the light stimulus. Changes are plotted as percentage of control 
(100%). (A) The plateau of both the rod-and cone-driven ONR was decreased in response to cholinergic agonists (A): ACh 
(400-800/aM, square) and carbachol (24-48 #M, diamond) injected for 25 and 12 min induced adecrease inplateau of the rod- 
driven ONR by up to 30% and 20%, respectively. ACh and carbachol were applied continuously and injected using incremental 
concentrations. Concentrations of 400/~M ACh for 10 min revealed similar effects on plateau of the cone-driven ONR 
corresponding toa decrease up to 55%. (B) Cholinergie antagonists induced an increase in plateau of both the rod-and cone- 
driven ONR: the plateau of the rod-driven ONR was increased by up to 65% and 110% in response to 200--400 pM scopolamine, 
and to 500 pM mecamylamine that was injected for 22 and 14 rain, respectively. (C) Maximal changes in normalized 
amplitudes of the ONR plateau in relation to the concentration f cholinergic agents, where open symbols represent agonists and 
solid symbols antagonists. Several incremental concentration series are included as separate data points. A dose-response 
relation is apparent for ACh and carbachol. An initial small increase followed by a long lasting decrease (arrow) was observed 
for three out of seven concentrations of cholinergic agonists. The main effect of agonists was a decrease inthe ONR plateau. The 
antagonists scopolamine and mecamylamine (solid symbols) consistently induced an increase in the plateau. 
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nicotinic transmission i  the dark-adapted cat eye. In 
accordance with the effects of ACh on the cone-driven b-
wave, the action of scopolamine was stronger on the 
cone-than on the rod-driven signals. However, the 
nicotinic antagonist mecamylamine was not more 
effective in the cone-driven compared to that on the 
rod-driven b-wave. 
Cholinergic agonists and' ONR 
ACh consistently induced a decrease in the ONR 
components, frequently preceded by a brief initial 
increase in the ON-component. The decrease of ONR- 
components was observed in spite of a simultaneous 
increase in flow rate (that per se would tend to increase 
the signal size). This observation provides evidence that 
the cholinergic effects represent a distinct interaction 
with neural receptors in addition to glial (see above) and 
vascular effects. ACh attenuated the plateau-and OFF- 
components more than the ON-component. This attenua- 
tion of the ONR-plateau is likely to reflect inhibition of 
sustained ON-centre ganglion cell activity (Gerber & 
Niemeyer, 1988). Supporting evidence for inhibition of 
ON-centre ganglion cells by ACh is provided by single 
cell recordings of previous tudies in the cat (Straschill, 
1967; Straschill & Perwezin, 1973). Related observations 
are provided by single cell recordings of a study by Ikeda 
and Sheardown (1982), who reported that ACh sup- 
pressed the spontaneous firing (maintained discharge) of 
sustained ON-cells and enhanced that of sustained OFF- 
cells. ACh in the present experiments decreased the 
ONR-ON component, whLich may indicate some inhibi- 
tion of ON-centre cell activity. However, Schmidt et al. 
(1987), reported an increase in maintained ischarge of 
the retinal ganglion cell responses, including X-, Y-and 
sluggish cells. In their study ACh induced an increase in 
the light-evoked activity during centre, surround and 
whole-field stimulation, and ON-centre X-cells only were 
affected using low concentrations of ACh (100 pM). 
However, their experimental pproach differs from the 
perfused cat eye, where intra-arterially injected ACh 
should reach all cholinergic sites in the retina approxi- 
mately at the same time. Thus, several factors may 
explain the varying restdts of single cell recordings 
(Straschill & Perwein, 19'73; Ikeda & Sheardown, 1982; 
Schmidt et al., 1987) compared to our study: (i) the use of 
different echniques, e.g. iontophoretic vs intra-arterial 
drug application and (ii) the use of mostly higher 
concentrations of ACh oampared to our study. Ionto- 
phoretic application of an agonist or antagonist toa single 
ganglion cell appears to :reflect changes different from 
those seen in the ONR that reflect rather effects on the 
neuronal network distal to the ganglion cells. 
The ONR thus is understood to comprise the firing 
patterns of all participating axons from all types of 
ganglion cells in the cat retina, reflecting both, excitation 
and inhibition (Niemeyer, 1989). The drug-induced 
changes are interpreted as alteration of the balance 
between excitatory and inhibitory events reflecting the 
"retinal output". The initial increase and the subsequent 
decrease of the ONR ON-component during ACh 
application may reflect the effects of ACh on both 
excitatory and inhibitory synapses. This biphasic ACh 
effect, excitation followed by inhibition, was also 
observed in cortical and brainstem neurons (Bradley, 
Dhawan & Wolstencraft, 1966; Crawford & Curtis, 
1966). This may provide vidence for an initial excitatory 
ACh effect followed by an indirect, GABA-mediated 
inhibitory effect on the ONR: cholinergic amacrine cells 
have been shown to contain and release GABA (Chunn, 
W/issle & Brecha, 1988). Linn and Massey (1992) 
suggested that GABA may inhibit the light-evoked ACh 
release via negative feedback onto bipolar cell terminals. 
Therefore, the cholinergic and GABAergic amacrine cell 
may provide a feedback circuit, activated whenever the 
ACh concentration exceeds steady-state levels. Evidence 
for this regulatory mechanism via negative feedback 
might be expressed inour results, where the major effect 
of ACh was a decrease in the ONR components. 
Cholinergic antagonists and ONR 
The muscarinic antagonist scopolamine dearly re- 
vealed biphasic effects on the ONR-ON component 
under both rod-and cone-selective stimulation. This can 
be interpreted as a competitive interaction with endo- 
genous ACh on cholinergic receptors: the ON-component 
of the rod-driven ONR was transiently enhanced, while 
inhibitory effects were maximal following the end of 
drug administration. The increase in the plateau was also 
observed under administration f the muscarinic antago- 
nist QNB in preliminary studies (Niemeyer, Jurklies, 
Kaelin-Lang & Bittiger, 1995), implying a specific action 
on the muscarinic receptor. An earlier study on effects of 
atropine on the perfused eye also revealed a dose- 
dependent attenuation of the ONR (Niemeyer & 
Cervetto, 1977). 
The inhibitory effect of scopolamine on the ONR 
corroborates arlier ecordings from ganglion cells: intra- 
arterial application to perfused cat eyes of the muscarinic 
antagonist a ropine induced adepression of both, ON-and 
OFF-centre cells in their light-evoked centre response as 
well as in their maintained activity (Niemeyer et al., 
1981). Schmidt et al. (1987) observed a decrease in 
stimulus induced and maintained firing of the studied 
ganglion cell types in response to iontophoretically 
applied scopolamine (100/~M). However, in the present 
study we observed a remarkable and reproducible 
depression of the ONR-ON component immediately after 
stop of scopolamine injection. Other mechanisms may be 
responsible for these anticholinergic effects: antagonists 
could potentiate ACh release possibly due to the block of 
autoreceptors (Kilbinger, 1989) or due to an feedback 
to cholinergic amacrine cells involving glycinergic 
interneurons (Cunningham, Dawson & Neal, 1983). 
Muscarine nhanced the release of glycine from amacrine 
cells, while atropine reduced this release of glycine and 
enhanced the release of ACh in their study. Neal and 
Cunningham (1994) suggest that muscarinic receptors on 
glycinergic amacrine cells are blocked by antagonists, 
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like atropine, reducing the release of glycine. This would 
reduce the glycinergic inhibitory feedback and enhance 
the release of ACh. The biphasic effect of scopolamine 
on the ONR in the present study [shown in Fig. 5(B)] may 
be due to the following mechanisms: scopolamine 
induces a transient increase in the ON-component, but 
the inhibition of presynaptic (muscarinic) autoreceptors 
or muscarinic receptors on glycinergic amacrine cells 
generates an increase in ACh. The latter could diminish 
the antimuscarinic effects and recover the ON-compo- 
nent o normal values during application of scopolamine. 
A steady state is reached on the muscarinic receptors. The 
termination of injection and the washout of the 
antimuscarinic drug will disturb this balance, and 
released ACh would bind to the cholinergic receptors, 
inducing a marked ecrease in the ONR components. 
The nicotinic antagonist mecamylamine induced an 
increase in the plateau, similar to the effects of 
muscarinic antagonists and induced a decrease in the 
ONR ON-component in dark adaptation [Fig. 4(A), Fig. 5 
and Fig. 7]. We interpret his result as evidence for a 
nicotinic mechanisms in the cat retina, in accordance 
with Ikeda and Sheardown (1982). Further studies are 
needed to explain the different and variable action of 
mecamylamine under od vs cone stimuli. 
In conclusion, cholinergic antagonists modulate retinal 
signal processing, as clearly reflected in the ONR, 
complementing evidence reported from other labora- 
tories. The early part of the plateau was the most 
susceptible component in response to cholinergic agents: 
nicotinic and muscarinic antagonists induced an increase 
in the plateau under both rod-and cone-selective 
stimulation. The effects of cholinergic antagonists on 
the ONR-ON component were different for rod vs cone 
function: the increase in ON-component induced by 
mecamylamine was more pronounced under cone-driven 
than under rod-driven stimulus conditions. The results 
suggest a role of nicotinic receptors for the ONR 
particularly under cone-selective stimulation. The 
changes in ONR-components induced by muscarinic 
antagonists uggest that also muscarinic receptors 
modulate the signal processing in the retina. Sannita, 
Balestra, DiBon, Marotta and Rosadini (1993) observed 
distinct changes in N2-P3 pattern ERG-components and 
in EEG components in human volunteers in response to 
i.m. applied scopolamine. These results suggest hat 
muscarinic receptors in the retina might contribute to the 
changes in the visually evoked reponses. 
Variability of responses to cholinergic agents 
Within the limits of this experimental study, choliner- 
gic agents induced occasionally variable changes, 
especially on the b-wave, while the ONR-plateau was 
uniformly depressed by agonists and increased by 
antagonists. Dose-response curves, e.g. for ACh and 
the rod b-wave were not always monotonic. 
Muscarinic receptors comprise a class of heteroge- 
neous receptors, consisting of M1 and M2 receptors. Both 
are distributed in the central nervous ystem (Hammer, 
Berrie, Birdsall, Burgen & Hulme, 1980; Hammer & 
Giacchetti, 1982). Several muscarinic agents showed 
differential interaction with distinct M1 and M2 binding 
sites, e.g. carbachol prefers the M2 type. This might 
contribute to the occasionally variable changes in 
response to cholinergic agents in the present study. It 
uggests a further subclassification of these receptor 
types (Watson, Roeske & Yamamura, 1986a; Watson, 
Yamamura & Roeske, 1986b). However, to our knowl- 
edge no data are available about he subclassification f 
muscarinic receptor types in the cat retina. Several 
authors argued that some antagonists change the 
isomerization of muscarinic receptors and enhance their 
affinity (Schreiber & Sokolovsky, 1985; Luthin & Wolfe, 
1984). Wamsley, Zarbin, Birdsall and Kuhar (1980) 
reported high and low affinity sites of cholinergic 
receptors: antagonists have high affinities to all receptor 
sites, while agonists can bind to three different sites of the 
receptor with different affinities. These may be reasons 
for the difficulty in obtaining consistent effects with 
cholinergic agonists and antagonists. 
Possible sites of action 
Previous reports have provided evidence for both 
nicotinic (Ikeda & Sheardown, 1982)and muscarinic 
(Straschill & Perwein, 1973) action in the cat retina. 
Schmidt et al. (1987) reported evidence favouring the 
muscarinic pathway. Our results suggest that both 
receptor types play a role in retinal neurotransmission. 
Supporting evidence comes from autoradiographic stu- 
dies: Pourcho and Osman (1987) detected nicotinic and 
muscarinic binding sites in the inner plexiform layer and 
nicotinic binding sites in the ganglion cell layer of the cat 
retina. Muscarinic binding sites were detected inthe GCL 
and INL of the human, rat and monkey retina (Zarbin et 
al., 1986). The subpopulation f starburst amacrine cells 
(A14) in rabbit was shown to synthesize and release ACh 
(Masland & Mills, 1979; Tauchi & Masland, 1984; 
Masland, Mills & Cassidy, 1984a; Masland, Mills & 
Hayden, 1984b). The consistent and generally dose- 
related changes in the ONR reported here confirm that 
cholinergic agents predominantly act in the proximal 
layers of the retina. This concept is supported by 
intracellular ecordings from horizontal cells in the 
perfused cat eye that suggested the absence of effects 
of muscarinic and nicotinic antagonists in the outer etina 
(Niemeyer et al., 1981). 
Consequently, changes in ONR in our study suggest 
that cholinergic agents may predominantly modulate 
neurotransmission via amacrine cells to the ganglion cell 
layer. The action of amacrine cells is likely to affect 
retrogradely the b-wave generating mechanisms in a 
different way than the third-order neurons. Furthermore, 
our findings support he view that both, nicotinic and 
muscarinic mechanisms are clearly expressed in the 
summed firing activity of axons, reflected in the ONR. 
Within this complex signal the plateau evolved as the 
component most suceptible to exogenous cholinergic 
agents. 
CHOLINERGIC EFFECTS ON CAT RETINA 815 
REFERENCES 
Ariel, M. & Daw, N. W. (1982a). Effects of cholinergic drugs on 
receptive field properties of rabbit retinal ganglion cells. Journal of 
Physiology, London, 324, 13:5-160. 
Ariel, M. & Daw, N. W. (~[982b). Pharmacological nalysis of 
directionally sensitive rabbit retinal ganglion cells. Journal of 
Physiology, London, 324, 161-185. 
Bradley, P. B., Dhawan, B. N. & Wolstencrafi, J. H. (1966). 
Pharmacological properties of cholinoceptive neurons in the 
medulla and the pons of the cat. Journal of Physiology, London, 
183, 658--674. 
yon Bredow, J., Bay, E. & Adtams, N. (1971). Drug actions on the 
central nervous system as studied by effects on the 
electroretinogramm. Experimental Neurology, 33, 45-52. 
Chunn, M.-H., W~issle, H. & Brecha, N. (1988). Colocalization of 
[3H]muscimol uptake and choline acetyltransferase immunoreac- 
tivity in amacrine cells of the cat retina. Neuroscience L tters, 94, 
259-263. 
Crawford, J. M. & Curtis, D. R. (1966). Pharmacological studies on 
feline Betz cells. Journal of l'hysiology, London, 186, 121-138. 
Cunningham, J. R., Dawson, C. & Neal, M. J. (1983). Evidence for a 
cholinergic inhibitory feed-back mechanism in the rabbit retina. 
Journal of Physiology, London, 340, 455-468. 
Demant, E., Nagahara, K. & Niemeyer, G. (1982). Effects of changes 
in systemic blood pressure on the electroretinogram of the cat: 
Evidence for retinal autoregulation. I vestigative Ophthalmology & 
Visual Science, 23, 683--687. 
Eckenstein, F., Schwab, M. & Thoenen, H. (1981). Cholineacetyl- 
transferase: Purification and immunofluorescent localization in 
retina of four vertebrate species. Society for Neuroscience 
Abstracts, 7, 309. 
Famiglietti, E. V. (1983). ON and OFF pathways through amacrine 
cells in mammalian retina: The synaptic onnections of "Starburst" 
amacrine cells. Vision Research, 23, 1265-1279. 
Gerber, U. & Niemeyer, G. (1988). fl-Adrenergic antagonists modify 
retinal function in the perfused cat eye. Clinical Vision Sciences, 3, 
255-266. 
Gouras, P. & Hoff, M. (1970). Retinal function in an isolated, perfused 
mammalian eye. Investigative Ophthalmology, 9, 388-399. 
Hammer, R., Berrie, C. P., Bir,:lsall, N. J. M., Burgen, A. S. V. & 
Hulme, E. C. (1980). Pirenzepine distinguishes between different 
subclasses of muscarinic receptors. Nature, 283, 90-92. 
Hammer, R. & Giacchetti, A. (11982). Muscarinic receptor subtypes: 
M1 and M2. Biochemical and functional characterization. Life 
Sciences, 31, 2991-2998. 
Hirsch-Hoffmann, C. & Niemeyer, G. (1994). Changes in plasma 
glucose level affect rod-, but not cone-ERG in the anesthetized cat. 
Clinical Vision Sciences, 8, 489-501. 
Honda, K. (1971). Studies on the. electrical activity of the mammalian 
retina in vitro. 3. The effects of acetylcholine upon the ERG of 
rabbit's retinas in vitro. Acta Societatis Ophthalmologicae 
daponicae, 75, 1164-1171. 
H6sli, L., H6sli, E. & K/iser, H. (1993). Peptidergic and cholinergic 
colocalization of cholinergic, adrenergic, and peptidergic receptors 
on astrocytes. Neuroreport, 4, 679-682. 
H6sli, L., H6sli, E., Maelicke, A. & Schr6der, H. (1992). Peptidergic 
and cholinergic receptors on cultured astrocytes. Progress in Brain 
Research, 94, 317-329. 
Hutchins, J. B. & HoUyfield, J. G. (1987). Cholinergic neurons in the 
human retina. Experimental Eye Research, 44, 363-375. 
Ikeda, H. & Sheardown, M. J. (1982). Acetylcholine may be an 
excitatory transmitter mediating visual excitation of "transient" 
cells with the periphery effect in the cat retina: lontophoretic studies 
in vivo. Neuroscience, 7 1299-1308. 
Jurklies, B., Kaelin, A. & Niemeyer, G. (1994). Effects of cholinergic 
agents on circulation in the perfused cat eye. German Journal of 
Ophthalmology, 3, 294. 
Kaelin-Lang, A. & Niemeyer, G. (1995). A PC program for the 
analysis of electrophysiological signals recorded from the mamma- 
lian eye. Klinische Monatsbl~tter far Augenheilkunde. 206, 394- 
396. 
Kilbinger, H. (1989). Neuronal muscarine receptors modulating 
acetylcholine release. In van Zwieten, P. A. & Sch6nbaum, E. 
(Eds), Modern developments in cholinergie (muscarinic) receptors 
and drugs (pp. 33-40). Stuttgart: Fischer. 
Linn, D. M. & Massey, S. C. (1992). GABA inhibits ACh release from 
the rabbit retina: A direct effect or feedback to bipolar cells? Visual 
Neuroscience, 8 97-106. 
Luthin, G. R. & Wolfe, B. B. (1984). 3H pirenzepine and 3H- 
quinuclidinilbenzylate binding to brain muscarinic receptors. 
Molecular Pharmacology, 26, 164-169. 
Masland, R. H. (1980). Acetylcholine in the retina. Journal of 
Neurochemistry, 1, 501-518. 
Masland, R. H. (1982). Evidence for the two kinds of acetylcholine 
release by an identified neuron. Society for Neuroscience Abstracts, 
8, 519. 
Masland, R. H. & Ames, A. (1976). Responses to acetylcholine of
ganglion cells in an isolated mammalian retina. Journal of 
Neurophysiology, 39, 1220-1233. 
Masland, R. H. & Mills, J. W. (1979). Autoradiographic identification 
of acetylcholine in the rabbit retina. Journal of Cellular Biology, 83, 
159-178. 
Masland, R. H., Mills, J. W. & Cassidy, C. (1984a). The functions of 
acetylcholine in the rabbit retina. Proceedings of the Royal Society 
of London B, 223, 121-139. 
Masland, R. H., Mills, J. W. & Hayden, S. A. (1984b). Acetylcholine- 
synthesizing amacrine cells: Identification and selective staining by 
using radioautography and fluorescent markers. Proceedings of the 
Royal Society of London B, 223, 79-100. 
Nakagawa, T., Kurasaki, S., Masuda, T., Ukai, IC, Kubo, S. & Kadono, 
H. (1988). Effects of some psychotropic drugs on the b-wave of the 
electroretinogram in isolated rabbit retina. Japanese Journal of 
Pharmacology, 46, 97-100. 
Neal, M. J. (1983). Cholinergic mechanisms in the vertebrate r tina. 
Progress in Retinal Research, 2, 191-212. 
Neal, M. J. & Cunningham, J. R. (1994). Baclofen enhances amacrine 
cell acetylcholine release by reducing glycinerglc feedback 
inhibition. Investigative Ophthalmology & Visual Science, 35, 519. 
Newman, E. A. (1985). Regulation of extracellular potassium by glial 
cells in the retina. Trends in Neuroscience, 8, 156-159. 
Nichols, C. W. J., Hewitt, J. & Laties, A. M. (1972). Localization of 
acetylcholinesterase in the teleost retina. Journal of Histochemistry 
and Cytochemistry, 20, 130-136. 
Niemeyer, G. (1973). ERG dependence of flow rate in the isolated 
perfused mammalian eye. Brain Research, 57, 203-207. 
Niemeyer, G. (1981). Neurobiology of perfused mammalian eyes. 
Journal of Neuroscience Methods, 3, 317-337. 
Niemeyer, G. (1989). The optic nerve action potential: A monitor for 
pharmacological effects in the perfused cat eye. In Cordelia, 
Macaluso, C. (Ed.), Le indagini elettrofisiologiche n Ue affezioni 
del nervo ottico (pp. 65-80). Parma: University of Parma. 
Niemeyer, G. (1992). The isolated arterially perfused mammalian eye. 
In Kettenmann, H. & Grantyn, R. (Eds), Practical electrophysiolo- 
gical methods (Chap. 2.1, pp. 31-35). New York: Wiley. 
Niemeyer, G., Albani, C. & Schuurmans, R. (1981). Transmitter- 
related studies in the isolated, perfused eye of the cat. Vision 
Research, 21, 1661-1663. 
Niemeyer, G. & Cervetto, L. (1977). Effects of atropine on ERG and 
optic nerve response in the cat retina. Documenta Ophthalmologica 
Proceedings Series, 13, 307-313. 
Niemeyer, G., Jurkiies, B., Kaelin-Lang, A. & Bittiger, H. (1995). 
Binding and electrophysiology of the muscarinic antagonist QNB in 
mammalian retina. Klinische Monatsbli~tter fa Augenheilkunde. In 
press. 
Pourcho, R. & Osman, K. (1986). Cytochemical identification of 
cholinergic amacfine cells in cat retina. Journal of Comparative 
Neurology, 247, 497-504. 
Pourcho, R. & Osman, IC (1987). Lamination of cholinergic markers 
in the cat retina. Investigative Ophthalmology & Visual Science 
(Suppl.), 28, 278. 
Puro, D. G. (1985). Cholinergic systems. In Morgan, W. W. (Ed.), 
816 BERNHARD JURKLIES et al. 
Retinal transmitters and modulators: Models for the brain (pp. 63- 
91). Boca Raton, FL: CRC Press. 
Sannita, W. G., Balestra, V., DiBon, G., Marotta, V. & Rosadini, G 
(1993). Human flash-VEP and quantitative EEG are independently 
affected by acute scopolamine. Electroencephalography and 
Clinical Neurophysiology, 86, 275-282. 
Schmidt, M., Humphrey, M. F. & W/issle, H. (1987). Action and 
localization of acetylcholine in the cat retina. Journal of 
Neurophysiology, 58, 997-1015. 
Schreiber, G. & Sokolovsky, M. (1985). Muscarinic receptor 
heterogeneity revealed by interaction with bretylium tosilate. 
Molecular Pharmacology, 27, 27-31. 
Sieving, P. A., Murayama, K. & Naarendorp, F. (1994). Push-pull 
model of the primate photopic electroretinogram: A role for 
hyperpolarizing neurons in shaping the b-wave. Visual 
Neuroscience, 11,519-532. 
Straschill, M. (1967). Actions of drugs on single neurons in the cat's 
retina. Vision Research, 8, 35-47. 
Straschill, M. & Perwein, J. (1973). The effect of iontophoretically 
applied acetylcholine upon the cat's retinal ganglion cells, Pfliigers 
Archiv, 339, 289-298. 
Tauchi, M. & Masland, R. H. (1984). The shape and arrangement of 
cholinergic neurons in the rabbit retina. Proceedings of the Royal 
Society of London B, 223, 101-119. 
Uji, Y. & Niemeyer, G. (1989). Electrophysiologicai studies employ- 
ing the perfused cat eye. In Mook of ophthalmology: Visual 
electrophysiology, 41, 30--49. 
Vivas, I. M. & Drujan, B. D. (1980). Certain aspects of acetylcholine 
metabolism in teleost retina. Neurochemical Research, 5, 817-829. 
Wamsley, J. K, Zarbin, M. A., Birdsall, M. J. M. & Kuhar, M. J. 
(1980). Muscarinic holinergic receptors: Autoradiographic locali- 
zation of high and low affinity agonist binding sites. Brain Research, 
200, 1-12. 
Watson, M., Roeske, W. R. & Yamamura, H. I. (1986a). 3H 
pirenzepine and (-)-3H quinuclidinylbenzilate binding to rat 
cerebral cortical and cardiac muscarinic holinergic sites. II. 
Characterization a d regulation of antagonist binding to putative 
muscarinic subtypes. Journal of Pharmacology and Experimental 
Therapeutics, 237, 419-427. 
Watson, M., Yamamura, H. I. & Roeske, W. R. (1986b). 3H 
pirenzepine and (--)-3H quinuclidinylbenzilate binding to rat 
cerebral cortical and cardiac muscarinic holinergic sites. I. 
Characterization and regulation of agonist binding to putative 
muscarinic subtypes. Journal of Pharmacology and Experimental 
Therapeutics, 237, 411-418. 
Wen, R. & Oaldey, B. I. (1990). K+-evoked Miiller cell depolarization 
generates b-wave of electroretinogram in toad retina. Proceedings of 
the National Academy of Science U.Sdi., 87, 2117-2121. 
Zarbin, M. A., Wamsley, J. Ko, Palacios, J. M. & Kuhar, M. J. (1986). 
Autoradiographic localization of high affinity GABA, benzodiaze- 
pine, dopaminergic, adrenergic and muscarinic cholinergic receptors 
in the rat, monkey, and human retina. Brain Research, 374, 75-92. 
Acknowledgements--We wish to thank Professor Laura Frishman for 
helpful comments on the manuscript and Mrs S. Sahli for competent 
technical assistance. 
